Sudden Death Clinical Trial
Official title:
Correlation Between Monitoring Frequency and Clinical Deterioration in Hospitalized Patients
Acute deterioration among hospitalised patient can result in serious adverse events like
cardiac arrest, unexpected death or unanticipated intensive care unit (ICU) admission. Most
events are preceeded by deteriorating vital signs, and potentially avoidable.
To detect and treat hospitalised at-risk patients early an early warning score (EWS) was
introduced at the investigator site. EWS measures of a number of physiological parameters
that are aggregated to a common score, that directs monitoring frequency, clinical
interventions and competency of the provider.
Patients with low scores (0 - 1) are monitored every 12th hour and seldom experience serious
adverse events. The optimal monitoring frequency for this group is unknown, and presently
based on a compromise between patient safety and work load issues.
The aim of the present study is to explore if an 8 hourly monitoring interval (intervention)
is correlated with a better outcome than 12 hour intervals (control), based on the number of
patients that deteriorate to a higher EWS 24 hours after hospital admission in each group.
Acute deterioration among hospitalised patient can result in serious adverse events like
cardiac arrest, unexpected death or unanticipated intensive care unit (ICU) admission. Most
events are preceeded by deteriorating vital signs, and potentially avoidable.
To detect and treat hospitalised patients at risk of clinical deterioration in a timely
manner, an early warning score (EWS) was introduced at the investigator site. EWS includes
measures for respiratory rate, arterial hemoglobin oxygen saturation, pulse rate, systolic
blood pressure, level of consciousness according to AVPU score, temperature, and whether a
patient receives supplementary oxygen. Each vital sign can be assigned between 0 to 3 points
(supplementary oxygen 0 or 2) depending on how much it deviates from a predefined threshold;
the values are added to an aggregated score from 0 to 20, higher scores indicating more
severe disease. An escalation protocol that directs the type of clinical response and
competency of the provider according to EWS triggers was also introduced as an integrated
part of the system.
Patients with low scores (0 - 1) are monitored every 12th hour and seldom experience serious
adverse events. The optimal monitoring frequency for this group is unknown, and presently
based on a compromise between patient safety and work load issues.
The aim of the present study is to explore if an 8 hourly monitoring interval (intervention)
is correlated with a better outcome than 12 hour intervals (control) in the group of
patients that have an EWS of 0 or 1 on admission. Deterioration is based on the number of
patients that deteriorate to a higher EWS 24 hours after the first EWS is measured. Since
serious adverse events in this population are rare the primary outcome is clinical
deterioration defined as number of patients with elevated EWS >/= 2 in each group, 24 hours
after admission to the hospital.
This is a cluster-randomized, non-blinded, pragmatic, interventional study of acutely
admitted, adult patients to surgical or medical wards at our hospital.
;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01185756 -
MIBG Scintigraphy as a Tool for Selecting Patients Requiring Implantable Cardioverter Defibrillator (ICD)
|
N/A | |
Active, not recruiting |
NCT02933437 -
The Response To Ajmaline Provocation in Healthy Subjects
|
Phase 2 | |
Recruiting |
NCT02920203 -
Genetic Autopsy and Sudden Death
|
N/A | |
Recruiting |
NCT02816047 -
Austrian Wearable Cardioverter Defibrillator Registry
|
||
Completed |
NCT04918303 -
Skin Sympathetic Nerve Activity and Cardiac Arrhythmia
|
N/A | |
Recruiting |
NCT00469794 -
The Significance of Arrhythmias in Athletes
|
N/A | |
Completed |
NCT00692666 -
Letigen® and Cardiovascular Morbidity
|
Phase 4 | |
Completed |
NCT02527031 -
A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2)
|
N/A | |
Withdrawn |
NCT01422174 -
Clinical Registry on Sudden Death Primary Prevention at Latin America
|
N/A | |
Recruiting |
NCT00673842 -
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
|
Phase 3 | |
Completed |
NCT01326624 -
Study of the Wearable Defibrillator in Heart-Failure Patients
|
N/A | |
Recruiting |
NCT01847378 -
Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias
|
N/A | |
Recruiting |
NCT00741728 -
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
|
N/A | |
Completed |
NCT01446965 -
Vest Prevention of Early Sudden Death Trial and VEST Registry
|
N/A | |
Recruiting |
NCT02732067 -
Death Rate in Anesthesia, a Study in a Tertiary Hospital
|
N/A | |
Recruiting |
NCT02685540 -
Death Rate in Anesthesia: A Study in a Tertiary Hospital
|
N/A | |
Completed |
NCT01804439 -
Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes
|
N/A | |
Completed |
NCT03320902 -
Sudden Death Counselling and Its Impact on Family Members of Sudden Death Victims
|
N/A | |
Recruiting |
NCT02874469 -
Impact of an Intensive Care Diary on Post-traumatic Stress Disorder After a Resuscitated Sudden Death
|
N/A | |
Completed |
NCT03111043 -
Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors
|